Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9021 |
High Similarity |
NPD1653 |
Approved |
0.8421 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8207 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8201 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8176 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8156 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8105 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8099 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8099 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8074 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.8052 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7929 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7806 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7801 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7758 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7721 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7669 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7632 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7626 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7622 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD37 |
Approved |
0.7578 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7571 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD919 |
Approved |
0.7557 |
Intermediate Similarity |
NPD1358 |
Approved |
0.755 |
Intermediate Similarity |
NPD3750 |
Approved |
0.755 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7548 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7518 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6190 |
Approved |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1778 |
Approved |
0.747 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7425 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7421 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7405 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7333 |
Intermediate Similarity |
NPD228 |
Approved |
0.7324 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7293 |
Intermediate Similarity |
NPD290 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7286 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD411 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7152 |
Intermediate Similarity |
NPD920 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7103 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7095 |
Intermediate Similarity |
NPD7095 |
Approved |
0.709 |
Intermediate Similarity |
NPD968 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7075 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD1048 |
Approved |
0.7042 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7042 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7029 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7014 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7013 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6977
|
Remote Similarity |
NPD7685 |
Pre-registration |